Quantum Computing to collaborate with Sanders TDI

Quantum Computing (QUBT) announced a collaboration with Sanders Tri-Institutional Therapeutics Discovery Institute to drive advancement of research in computational biomedicine. Through this collaboration, QCi will provide Sanders TDI with access to its quantum computation technology and hardware, specifically with its Dirac-3 Entropy Quantum Computing Machine, to support the Institute’s experimental work. Sanders TDI is a non-profit drug discovery institute based in New York City, composed of Kettering Cancer Center, The Rockefeller University, and Memorial Sloan Weill Cornell Medicine. As part of the collaboration, QCi will offer Sanders TDI cloud-based access to its Dirac-3 systems, which operate at room temperature and low power and are designed to solve complex optimization problems. The collaboration will focus on advancing Sanders TDI’s computational chemistry research by leveraging quantum technologies, including quantum analog computers, for proof of concept calculations in biomolecular modeling. Recognizing the diverse set of potential use cases in this field, QCi will work closely with Sanders TDI to explore a variety of quantum-enabled applications, with the goal of identifying the most promising use cases for its Dirac systems.